Leadership
John McKinley
John has over three decades’ experience of board-level executive and NED chairman roles in private and publicly listed companies, government departments including public private industry partnerships in the UK and overseas. He has specialist expertise in diagnostic technologies, instruments and devices, particularly in highly infectious respiratory human and animal diseases, with a deep knowledge of translational population genomics and personalised medicine. John transitioned from a foundation career in corporate, commercial and licensing legal practice, the London insurance industry and ESG technologies to executive roles in global Life Science, biotechnology and environmental sector companies. Seasoned in engaging executives, shareholders and stakeholders at all levels of seniority, he articulates visions for business improvement and ESG aligning disparate parties towards common purposes and goals. As a result, he has launched and led a variety of companies from start-up to become publicly listed entities with robust ESG governance and expansive global commercial footprints. John’s insights into global healthcare policies, practical translational expertise and senior legal background will help guide Impex’s mission to become the global leader in next-generation breath diagnostics.
Santi Dominguez
Santi Dominguez is a business graduate-turned-entrepreneur. He co-founded companies in Spain and the UK, oversaw the acquisition of G.A.S. GmbH, (Imspex Diagnostics subsidiary) in 2012. Santi is a Board member for life science technology companies in Spain, UK, Germany and California. He is passionate about driving innovation through Volatile Organic Compound (VOC) analysis.
David Wilson
David Wilson brings over 30 years of international leadership in the diagnostics industry. His expertise spans mergers and acquisitions, business development, and global sales. David has held key roles at companies like Genzyme Corporation and Avacta Group Plc., where he drove strategic growth and innovation in diagnostics. His extensive background in public and private sectors strengthens Imspex’s mission to deliver cutting-edge solutions for clinical and industry testing needs. David’s vision and experience are pivotal to Imspex’s corporate and commercial growth.
Toby Wilson Waterworth
30 years’ senior corporate and operational experience in M&A, development of health tech companies, raising $200m in debt and equity, delivering $1bn in value. Global experience. Fellow of Institute of Chartered Accountants.
Amber Jacobs ACIM CMktr
Amber has over a 15 years’ experience in healthcare and life sciences start ups specialising in primary PR, marketing and social media strategies and management. A skilled Business Development executive of Life Science and IVD Medical Diagnostics instruments and devices. Amber is an associate member and chartered marketer with the Chartered Institute of Marketing.
Lisa Davies
Lisa brings over 30 years experience in administration and finance, including her time at HMRC and 11 years as the backbone of Imspex. She is highly skilled in managing financial systems, group administration, and ensuring compliance within regulated environments.
Hannah Deane-Cutler
Hannah has over a decade of experience in pharmaceutical, healthcare and physiology sectors. She is experienced in GC-IMS technology and holds a Master’s degree focused on its research capabilities within clinical and industrial settings, including the explorations of its practical applications.